The American Hospital of Paris performs over 2,300 IVF procedures annually, integrating artificial intelligence (AI) to enhance embryo selection. AI tools utilize data from embryoscopes, assessing factors like shape and cell division, to identify embryos with the highest implantation potential. This advancement aims to minimize costly IVF cycles by excluding embryos likely to have abnormalities, which cause miscarriages. AI, sourced from the Israeli start-up AIVF, could cut the number of IVF attempts in half, raising the likelihood of successful pregnancies to 70%. While AI helps optimize hormone treatments and sperm retrieval, some experts caution about the ethical implications of allowing algorithms to influence embryo selection. Bioethicist Julian Koplin advocates informing patients and offering opt-out options. Despite concerns, many researchers stress AI’s potential benefits in personalizing assistance for hopeful parents, ultimately reducing emotional distress associated with the IVF journey. As AI technology evolves, ongoing discussions about its ethical use in reproductive health continue.
Source link
